About
CAR-T Therapies
Areas of Focus
Categories
Stem Cell & Cellular TherapyVirginia, DC, DE & Maryland
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
131
By Phase
PHASE1: 1NA: 2EARLY_PHASE1: 1PHASE1/PHASE2: 1
By Status
UNKNOWN: 3NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05319314Lead Sponsor
GCC19CART for Patients With Metastatic Colorectal Cancer
PHASE1Unknown
30 participants
Started: Aug 1, 2022 · Completed: Oct 31, 2024
NCT04780529Lead Sponsor
CART Therapy in Digestive System Tumors
NANot yet recruiting
20 participants
Started: Mar 31, 2021 · Completed: Mar 31, 2026
NCT04652219Collaborator
CART Therapy in GUCY2C-positive Digestive Tract Tumors
EARLY_PHASE1Completed
1 participants
Started: Oct 10, 2020 · Completed: Oct 9, 2021
NCT03118180Collaborator
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
PHASE1/PHASE2Unknown
50 participants
Started: Apr 5, 2017 · Completed: Dec 31, 2020
NCT02813837Lead Sponsor
Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies
NAUnknown
30 participants
Started: Jun 30, 2015 · Completed: Jul 31, 2021
Locations (1)
Headquarters
Rockville, MD, United States
Map
Loading map...